Dr. Ruth O'Regan is Professor and Vice Chair for Educational Affairs, Hematology and Oncology at the Emory Winship Cancer Institute and Director of Winship's Translational Breast Cancer Research Program. Before coming to Winship, Dr. O'Regan was at Northwestern University in Chicago where she was an assistant professor of Medicine. While at Northwestern she worked with one of the world's leading authorities, Dr. V. Craig Jordan, studying the mechanisms of selective estrogen receptor modulator or SERM resistance.
Dr. O'Regan is widely published in peer reviewed scientific journals, having published articles in journals, such as Lancet Oncology, the Journal of the National Cancer Institute and the Journal of the American Medical Association. Dr. O'Regan speaks nationally on topics related to breast cancer, including the use of hormonal and targeted therapies. Dr. O'Regan is a current member of the breast cancer scientific committee of the American Society of Clinical Oncology.
A native of Dublin, Ireland, Dr. O'Regan earned her medical degree at University College in Dublin. She conducted a residency in Internal Medicine and a Fellowship in Oncology at the Mater Hospital, in Dublin. She did her U.S. residency and fellowship at Northwestern University, Chicago, and joined the faculty there in 1999. While at Northwestern, she won the Compassionate Care Award from the Women's Board of Northwestern Hospital and the NSABP Young Clinical Investigator Award in 2001.
Martha L. Arellano, MD is Associate Professor of Hematology and Medical Oncology at Emory University School of Medicine and a member of the Winship Cancer Institute of Emory University in Atlanta, Georgia. Dr. Arellano received her Medical Degree in 2000, completed Internal Medicine residency in 2003, and Hematology/Oncology fellowship in 2006 at Emory University School of Medicine. Dr. Arellano is actively involved in the training of fellows, medical students, and house staff, specifically focusing on diagnosis and management of hematological disorders.
Dr. Arellano is an active clinical investigator with a primary focus on developing novel therapies for adults with acute leukemias and myelodysplastic syndromes, and immune-based therapies for hematological malignancies. She has published in leading journals including Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation and Leukemia and Lymphoma, among others. She serves on multiple committees at the Winship Cancer Institute of Emory University including, the Data Safety Monitoring Committee (DSMC), Chemotherapy Quality and Safety Council, and the Pharmacy and Therapeutics Subcommittee. She has also served on the University’s Community and Diversity Committee to develop strategies for retention and development of students and trainees at Emory University. Dr. Arellano participates in the American Society of Hematology Grassroots Network and was nominated to the Advocacy Leadership Institute.